薬物乱用検査の世界市場2019-2029

LINEで送る

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Market Background

3.1. Macro-Economic Factors

3.1.1. Growing Impact of Drug and Alcohol Abuse on Public Health

3.1.2. Rise in Law Enforcement Spending for Illicit Drug Interdiction

3.2. Forecast Factors – Relevance & Impact

3.2.1. Rise in Number of Clinical Laboratories offering Drugs of Abuse Testing Services

3.2.2. Awareness Initiatives from the Manufacturers

3.2.3. Rising R&D investments

3.2.4. Drug Abuse Testing Regulation

3.3. Market Dynamics

3.3.1. Drivers

3.3.2. Restraints

3.3.3. Opportunity Analysis

4. Global Drug of Abuse Testing Market Demand (Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

4.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

4.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Drug of Abuse Testing Market Analysis 2014-2018 and Forecast 2019-2029, by Drug Type

5.1. Introduction / Key Findings

5.2. Historical Market Size (US$ Mn) Analysis By Drug Type, 2014–2018

5.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Type, 2019-2029

5.3.1. Psychostimulants

5.3.2. Narcotics

5.3.3. Cannabinoids

5.3.4. Sedatives

5.3.5. Others

5.4. Market Attractiveness Analysis By Drug Type

6. Global Drug of Abuse Testing Market Analysis 2014-2018 and Forecast 2019-2029, by Technique

6.1. Introduction / Key Findings

6.2. Historical Market Size (US$ Mn) Analysis By Technique, 2014–2018

6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technique, 2019-2029

6.3.1. Immunoassay

6.3.2. Chromatography

6.3.3. Rapid Testing

6.4. Market Attractiveness Analysis By Technique

7. Global Drug of Abuse Testing Market Analysis 2014-2018 and Forecast 2019-2029, by End User

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Mn) Analysis By End User, 2014–2018

7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2019-2029

7.3.1. Hospitals

7.3.2. Diagnostics Laboratories

7.3.3. Forensic Laboratories

7.3.4. Others

7.4. Market Attractiveness Analysis By End User

8. Global Drug of Abuse Testing Market Analysis 2014-2018 and Forecast 2019-2029, by Region

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Region, 2014–2018

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2019-2029

8.3.1. North America

8.3.2. Latin America

8.3.3. Western Europe

8.3.4. Eastern Europe

8.3.5. APEJ

8.3.6. Japan

8.3.7. MEA

8.4. Market Attractiveness Analysis By Region

9. North America Drug of Abuse Testing Market Analysis 2014-2018 and Forecast 2019-2029

9.1. Introduction

9.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

9.3.1. By Country

9.3.1.1. U.S.

9.3.1.2. Canada

9.3.2. By Drug Type

9.3.3. By Technique

9.3.4. By End User

9.4. Market Attractiveness Analysis

9.4.1. By Country

9.4.2. By Drug Type

9.4.3. By Technique

9.4.4. By End User

9.5. Key Market Participants – Intensity Mapping

9.6. Drivers and Restraints – Impact Analysis

10. Latin America Drug of Abuse Testing Market Analysis 2014-2018 and Forecast 2019-2029

10.1. Introduction

10.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

10.3.1. By Country

10.3.1.1. Brazil

10.3.1.2. Mexico

10.3.1.3. Rest of Latin America

10.3.2. By Drug Type

10.3.3. By Technique

10.3.4. By End User

10.4. Market Attractiveness Analysis

10.4.1. By Country

10.4.2. By Drug Type

10.4.3. By Technique

10.4.4. By End User

10.5. Key Market Participants – Intensity Mapping

10.6. Drivers and Restraints – Impact Analysis

11. Western Europe Drug of Abuse Testing Market Analysis 2014-2018 and Forecast 2019-2029

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

11.3.1. By Country

11.3.1.1. Germany

11.3.1.2. UK

11.3.1.3. France

11.3.1.4. Spain

11.3.1.5. Italy

11.3.1.6. Nordic Countries

11.3.1.7. Rest of WE

11.3.2. By Drug Type

11.3.3. By Technique

11.3.4. By End User

11.4. Market Attractiveness Analysis

11.4.1. By Country

11.4.2. By Drug Type

11.4.3. By Technique

11.4.4. By End User

11.5. Key Market Participants – Intensity Mapping

11.6. Drivers and Restraints – Impact Analysis

12. Eastern Europe Drug of Abuse Testing Market Analysis 2014-2018 and Forecast 2019-2029

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

12.3.1. By Country

12.3.1.1. Russia

12.3.1.2. Poland

12.3.1.3. Rest of EE

12.3.2. By Drug Type

12.3.3. By Technique

12.3.4. By End User

12.4. Market Attractiveness Analysis

12.4.1. By Country

12.4.2. By Drug Type

12.4.3. By Technique

12.4.4. By End User

12.5. Key Market Participants – Intensity Mapping

12.6. Drivers and Restraints – Impact Analysis

13. APEJ Drug of Abuse Testing Market Analysis 2014-2018 and Forecast 2019-2029

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

13.3.1. By Country

13.3.1.1. China

13.3.1.2. India

13.3.1.3. Australia & NZ

13.3.1.4. ASEAN

13.3.1.5. Rest of APEJ

13.3.2. By Drug Type

13.3.3. By Technique

13.3.4. By End User

13.4. Market Attractiveness Analysis

13.4.1. By Country

13.4.2. By Drug Type

13.4.3. By Technique

13.4.4. By End User

13.5. Key Market Participants – Intensity Mapping

13.6. Drivers and Restraints – Impact Analysis

14. Japan Drug of Abuse Testing Market Analysis 2014-2018 and Forecast 2019-2029

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

14.3.1. By Country

14.3.1.1. Japan

14.3.2. By Drug Type

14.3.3. By Technique

14.3.4. By End User

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Drug Type

14.4.3. By Technique

14.4.4. By End User

14.5. Key Market Participants – Intensity Mapping

14.6. Drivers and Restraints – Impact Analysis

15. Middle East and Africa Drug of Abuse Testing Market Analysis 2014-2018 and Forecast 2019-2029

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

15.3.1. By Country

15.3.1.1. GCC Countries

15.3.1.2. South Africa

15.3.1.3. Rest of MEA

15.3.2. By Drug Type

15.3.3. By Technique

15.3.4. By End User

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Drug Type

15.4.3. By Technique

15.4.4. By End User

15.5. Key Market Participants – Intensity Mapping

15.6. Drivers and Restraints – Impact Analysis

16. Competition Analysis

16.1. Competition Dashboard

16.2. Competition Benchmarking

16.3. Competition Deep Dive (Tentative List)

16.3.1. Quest Diagnostics

16.3.1.1. Overview

16.3.1.2. Service Portfolio

16.3.1.3. Profitability by Market Segments (Service/Channel/Region)

16.3.1.4. Sales Footprint

16.3.1.5. Strategy Overview

16.3.1.5.1. Marketing Strategy

16.3.1.5.2. Service Strategy

16.3.1.5.3. Channel Strategy

16.3.2. F. Hoffmann-La Roche Ltd

16.3.2.1. Overview

16.3.2.2. Service Portfolio

16.3.2.3. Profitability by Market Segments (Service/Channel/Region)

16.3.2.4. Sales Footprint

16.3.2.5. Strategy Overview

16.3.2.5.1. Marketing Strategy

16.3.2.5.2. Service Strategy

16.3.2.5.3. Channel Strategy

16.3.3. Siemens AG (Siemens Healthineers)

16.3.3.1. Overview

16.3.3.2. Service Portfolio

16.3.3.3. Profitability by Market Segments (Service/Channel/Region)

16.3.3.4. Sales Footprint

16.3.3.5. Strategy Overview

16.3.3.5.1. Marketing Strategy

16.3.3.5.2. Service Strategy

16.3.3.5.3. Channel Strategy

16.3.4. Thermo Fisher Scientific, Inc.

16.3.4.1. Overview

16.3.4.2. Service Portfolio

16.3.4.3. Profitability by Market Segments (Service/Channel/Region)

16.3.4.4. Sales Footprint

16.3.4.5. Strategy Overview

16.3.4.5.1. Marketing Strategy

16.3.4.5.2. Service Strategy

16.3.4.5.3. Channel Strategy

16.3.5. Abbott Laboratories (Alere, Inc.)

16.3.5.1. Overview

16.3.5.2. Service Portfolio

16.3.5.3. Profitability by Market Segments (Service/Channel/Region)

16.3.5.4. Sales Footprint

16.3.5.5. Strategy Overview

16.3.5.5.1. Marketing Strategy

16.3.5.5.2. Service Strategy

16.3.5.5.3. Channel Strategy

16.3.6. Shimadzu Corporation

16.3.6.1. Overview

16.3.6.2. Service Portfolio

16.3.6.3. Profitability by Market Segments (Service/Channel/Region)

16.3.6.4. Sales Footprint

16.3.6.5. Strategy Overview

16.3.6.5.1. Marketing Strategy

16.3.6.5.2. Service Strategy

16.3.6.5.3. Channel Strategy

16.3.7. Laboratory Corporation of America Holdings

16.3.7.1. Overview

16.3.7.2. Service Portfolio

16.3.7.3. Profitability by Market Segments (Service/Channel/Region)

16.3.7.4. Sales Footprint

16.3.7.5. Strategy Overview

16.3.7.5.1. Marketing Strategy

16.3.7.5.2. Service Strategy

16.3.7.5.3. Channel Strategy

16.3.8. Drägerwerk AG & Co. KGaA

16.3.8.1. Overview

16.3.8.2. Service Portfolio

16.3.8.3. Profitability by Market Segments (Service/Channel/Region)

16.3.8.4. Sales Footprint

16.3.8.5. Strategy Overview

16.3.8.5.1. Marketing Strategy

16.3.8.5.2. Service Strategy

16.3.8.5.3. Channel Strategy

16.3.9. Express Diagnostics International Inc.

16.3.9.1. Overview

16.3.9.2. Service Portfolio

16.3.9.3. Profitability by Market Segments (Service/Channel/Region)

16.3.9.4. Sales Footprint

16.3.9.5. Strategy Overview

16.3.9.5.1. Marketing Strategy

16.3.9.5.2. Service Strategy

16.3.9.5.3. Channel Strategy

17. Assumptions and Acronyms Used

18. Research Methodology




※当サイトのレポート紹介カバレッジ
■産業:医療、IT、電子、自動車、産業機械、建設、消費財、食品、化学、材料、エネルギー、金融、サービスなど多様
■地域:世界市場、アジア市場、中国市場、欧州市場、北米市場、中南米市場、中東市場、アフリカ市場など全世界
■レポート種類:市場動向、規模、占有率、トレンド、将来展望、未来予測、業界分析、産業分析、企業分析、事業機会分析、戦略提言など多様